Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This study is for patients with esophageal, esophagogastric, or gastric cancer that has
spread to other parts of the body. The purpose of this study is to test the safety and
effectiveness of a new experimental drug called ZD 1839 following initial therapy with two
other chemotherapy drugs, called Irinotecan (CPT-11) and Cisplatin.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute